1 |
Bai X, Ding SQ, Zhang XP, Han MH, Dai DQ. Exposure to Commonly Used Drugs and the Risk of Gastric Cancer: An Umbrella Review of Meta-Analyses. Cancers (Basel) 2023;15. [PMID: 36672322 DOI: 10.3390/cancers15020372] [Reference Citation Analysis]
|
2 |
Sosnowski K, Nehring P, Przybyłkowski A. Pancreas and Adverse Drug Reactions: A Literature Review. Drug Saf 2022. [PMID: 35788538 DOI: 10.1007/s40264-022-01204-0] [Reference Citation Analysis]
|
3 |
Zhang X, Shi J, Huang X, Shao B. Formation and occurrence of disinfection byproducts of benzodiazepine drug estazolam in drinking water of Beijing. Sci Total Environ 2022;804:150028. [PMID: 34798715 DOI: 10.1016/j.scitotenv.2021.150028] [Reference Citation Analysis]
|
4 |
Peng TR, Yang LJ, Wu TW, Chao YC. Hypnotics and Risk of Cancer: A Meta-Analysis of Observational Studies. Medicina (Kaunas) 2020;56:E513. [PMID: 33019585 DOI: 10.3390/medicina56100513] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
5 |
Hassinger AB, Bletnisky N, Dudekula R, El-Solh AA. Selecting a pharmacotherapy regimen for patients with chronic insomnia. Expert Opin Pharmacother 2020;21:1035-43. [PMID: 32202451 DOI: 10.1080/14656566.2020.1743265] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
|
6 |
Kripke DF. Hypnotic drug risks of mortality, infection, depression, and cancer: but lack of benefit. F1000Res 2016;5:918. [PMID: 27303633 DOI: 10.12688/f1000research.8729.3] [Cited by in Crossref: 46] [Cited by in F6Publishing: 47] [Article Influence: 6.6] [Reference Citation Analysis]
|
7 |
Kripke DF. Hypnotic drug risks of mortality, infection, depression, and cancer: but lack of benefit. F1000Res 2016;5:918. [PMID: 27303633 DOI: 10.12688/f1000research.8729.3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 36] [Article Influence: 2.0] [Reference Citation Analysis]
|